3170
M. Sisa et al.
SPECIAL TOPIC
HRMS: m/z calcd for C10H21NO5 (M + H+): 236.1498; found:
236.1498.
(4) El Ashry, E. S.; Rashed, N.; Shobier, A. H. Pharmazie 2000,
55, 403.
(5) El Ashry, E. S.; Rashed, N.; Shobier, A. H. Pharmazie 2000,
55, 331.
(6) El Ashry, E. S.; Rashed, N.; Shobier, A. H. Pharmazie 2000,
55, 251.
1-(3-Methylbutyl)amino-1-deoxy-scyllo-inositol (3g)
1H NMR (500 MHz, MeOD): d = 0.94 (d, J = 6 Hz, 6 H), 1.40–1.46
(m, 2 H), 1.57–1.73 (m, 1 H), 2.36–2.44 (m, 1 H), 2.89 (t, J = 8 Hz,
2 H), 3.13–3.28 (m, 5 H).
HRMS: m/z calcd for C11H23NO5 (M + H+): 250.1654; found:
250.1638.
(7) Lysek, R.; Schutz, C.; Favre, S.; O’Sullivan, A. C.; Pillonel,
C.; Krulle, T.; Jung, P. M.; Clotet-Codina, I.; Este, J. A.;
Vogel, P. Bioorg. Med. Chem. 2006, 14, 6255.
(8) Delgado, A.; Casas, J.; Llebaria, A.; Abad, J. L.; Fabrias, G.
Biochim. Biophys. Acta, Biomembr. 2006, 1758, 1957.
(9) Delgado, A.; Casas, J.; Llebaria, A.; Abad, J. L.; Fabrias, G.
ChemMedChem 2007, 2, 580.
(10) Clarke, J. H. Curr. Biol. 2003, 13, R815.
(11) Hudlicky, T.; Abboud, K. A.; Entwistle, D. A.; Fan, R.;
Maurya, R.; Thorpe, A. J.; Bolonick, J.; Myers, B. Synthesis
1996, 897.
1-Phenethylamino-1-deoxy-scyllo-inositol (3h)
1H NMR (500 MHz, MeOD): d = 2.58 (t, J = 10.5 Hz, 2 H), 2.79–
2.84 (m, 1 H), 3.10–3.26 (m, 7 H), 7.15–7.68 (m, 5 H).
HRMS: m/z calcd for C19H23NO5 (M + H+): 284.1498; found:
284.1500.
1-(2-Pyridylmethyl)amino-1-deoxy-scyllo-inositol (3i)
1H NMR (500 MHz, MeOD): d = 2.57–2.65 (m, 1 H), 3.11–3.31 (m,
not integrated, overlapped with MeOD), 4.18 (s, 2 H), 7.28–7.34
(m, 1 H), 7.44–7.52 (m, 1 H), 7.77–7.84 (m, 1 H), 8.49–8.55 (m, 1
H).
HRMS: m/z calcd for C12H18N2O5 (M + H+): 271.1294; found:
271.1285.
(12) Serrano, P.; Llebaria, A.; Delgado, A. J. Org. Chem. 2005,
70, 7829.
(13) Shing, T. K. M.; Li, T. Y.; Kok, S. H. L. J. Org. Chem. 1999,
64, 1941.
(14) Shing, T. K. M.; Tai, V. W. J. Org. Chem. 1995, 60, 5335.
(15) Fukase, H.; Horii, S. J. Org. Chem. 1992, 57, 3651.
(16) Horii, S.; Fukase, H.; Matsuo, T.; Kameda, Y.; Asano, N.;
Matsui, K. J. Med. Chem. 1986, 29, 1038.
(17) Serrano, P.; Casas, J.; Zucco, M.; Emeric, G.; Egido-Gabas,
M.; Llebaria, A.; Delgado, A. J. Comb. Chem. 2007, 9, 43.
(18) For a related reductive alkylation of an unprotected
aminocyclitol scaffold, see: Ogawa, S.; Mori, M.; Takeuchi,
G.; Doi, F.; Watanabe, M.; Sakata, Y. Bioorg. Med. Chem.
Lett. 2002, 12, 2811.
(19) Although the starting aminocyclitol 1 could be removed
from the reaction mixture by simple precipitation from
MeOH, this was not the case with aminocyclitol 2.
(20) Sato, S.; Sakamoto, T.; Miyazawa, E.; Kikugawa, Y.
Tetrahedron 2004, 60, 7899.
(21) The use of supported reagents and scavengers in
combinatorial chemistry protocols facilitates workup
procedures, allows the use of excess reagents, the reduction
of the reaction scale, and avoids the hazards associated to the
handling of toxic reagents, such as NaBH3CN.
(22) Several reaction systems were tried. Aminocyclitol 1 is only
slightly soluble in MeOH, MeCN, THF, i-PrOH, and
dioxane. In our reductive alkylation protocol with PSCBH,
addition of H2O increases the solubility of 1 at the expense
of the reaction rate, which became too slow for practical
purposes.
1-(2-Chloro-4-fluorobenzyl)amino-1-deoxy-D-chiro-inositol
(5c)
1H NMR (500 MHz, MeOD): d = 3.02–3.06 (m, 1 H), 3.53–3.60 (m,
2 H), 3.80–3.92 (m, 4 H), 4.07–4.11 (m, 1 H), 7.04–7.09 (m, 1 H),
7.19–7.24 (m, 1 H), 7.48–7.53 (m, 1 H).
HRMS: m/z calcd for C13H17ClFNO5 (M + H+): 322.0852; found:
322.0859.
1-(2-Methoxybenzyl)amino-1-deoxy-D-chiro-inositol (5j)
1H NMR (500 MHz, MeOD): d = 3.00 (t, J = 4.5 Hz, 1 H), 3.51–
3.59 (m, 2 H), 3.68 (d, J = 13.5 Hz, 2 H), 3.80–3.88 (m, 3 H), 3.86
(s, 3 H), 4.13 (t, J = 3.0 Hz, 1 H), 6.90 (t, J = 7.5 Hz, 1 H), 6.97 (d,
J = 7.5 Hz, 1 H), 7.25 (t, J = 7.5 Hz, 2 H).
HRMS: m/z calcd for C14H26NO6 (M + H+): 300.1447; found:
300.1436.
Acknowledgment
Partial financial support from the Ministerio de Ciencia y Tecnolo-
gía (Spain) (Project MCYT CTQ2005–00175/BQU), Fondos Feder
(EU), and Generalitat de Catalunya (Project 2005SGR0163) is
acknowledged. M.S. and A.T. are grateful to the Ministerio de Edu-
cación y Ciencia (Spain) for a post- and predoctoral fellowship, re-
spectively.
(23) Borch, R. F.; Bernstein, M. D.; Durst, H. D. J. Am. Chem.
Soc. 1971, 93, 2897.
(24) Despite formation of a putative intermediate oxazolidine,
arising from reaction of the initially formed imine with a
vicinal hydroxyl group cannot be ruled out,7 this did not
hamper the reactivity of our DMSO–AcOH system, since
aldehyde consumption was complete after 16 hours reaction
at r.t.
(25) Aldehydes 2a–c and 2j are benzaldehyde derivatives with
different electronic properties; 2e,f are a-branched aliphatic
aldehydes; 2g and 2h are b-branched (aliphatic or aromatic)
aldehydes; and 2i is an example of an heteroaromatic
aldehyde.
References
(1) On leave from IOCB (Institute of Organic Chemistry and
Biochemistry, Prague, Czech Republic).
(2) Mahmud, T. Nat. Prod. Rep. 2003, 20, 137.
(3) Ferrier, R. J.; Blattner, R.; Clinch, K.; Furneaux, R. H.;
Gardiner, J. M.; Tyler, P. C.; Wightman, R. H.; Williams, N.
R. In Specialist Periodical Reports, Carbohydrate
Chemistry, Vol. 28; Ferrier, R. J., Ed.; Royal Society of
Chemistry: Cambridge, 1996, 251.
(26) Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory
Chemicals; Pergamon Press: Oxford, 1988, 3rd ed.
Synthesis 2008, No. 19, 3167–3170 © Thieme Stuttgart · New York